JP2014501232A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501232A5
JP2014501232A5 JP2013543700A JP2013543700A JP2014501232A5 JP 2014501232 A5 JP2014501232 A5 JP 2014501232A5 JP 2013543700 A JP2013543700 A JP 2013543700A JP 2013543700 A JP2013543700 A JP 2013543700A JP 2014501232 A5 JP2014501232 A5 JP 2014501232A5
Authority
JP
Japan
Prior art keywords
phenyl
isopropyl
dihydroxy
triazole
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013543700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/072558 external-priority patent/WO2012084602A1/en
Publication of JP2014501232A publication Critical patent/JP2014501232A/ja
Publication of JP2014501232A5 publication Critical patent/JP2014501232A5/ja
Pending legal-status Critical Current

Links

JP2013543700A 2010-12-20 2011-12-13 抗腫瘍活性を有するアリールトリアゾール化合物 Pending JP2014501232A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195949.2 2010-12-20
EP10195949 2010-12-20
PCT/EP2011/072558 WO2012084602A1 (en) 2010-12-20 2011-12-13 Aryl triazole compounds with antitumoural activity

Publications (2)

Publication Number Publication Date
JP2014501232A JP2014501232A (ja) 2014-01-20
JP2014501232A5 true JP2014501232A5 (2) 2016-01-07

Family

ID=43901588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543700A Pending JP2014501232A (ja) 2010-12-20 2011-12-13 抗腫瘍活性を有するアリールトリアゾール化合物

Country Status (16)

Country Link
US (1) US9302998B2 (2)
EP (1) EP2655345B1 (2)
JP (1) JP2014501232A (2)
AR (1) AR084361A1 (2)
CY (1) CY1116297T1 (2)
DK (1) DK2655345T3 (2)
ES (1) ES2536980T3 (2)
HR (1) HRP20150450T1 (2)
HU (1) HUE025697T2 (2)
ME (1) ME02144B (2)
PL (1) PL2655345T3 (2)
PT (1) PT2655345E (2)
RS (1) RS53966B1 (2)
SI (1) SI2655345T1 (2)
SM (1) SMT201500115B (2)
WO (1) WO2012084602A1 (2)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014041106A1 (en) * 2012-09-17 2014-03-20 F. Hoffmann-La Roche Ag Triazole carboxamide derivatives
CN103275023B (zh) * 2013-06-08 2015-10-07 浙江工业大学 1-芳基-1,2,3-三氮唑类化合物及其制备和应用
CN107540624B (zh) * 2016-06-29 2020-06-16 广州市恒诺康医药科技有限公司 热休克蛋白抑制剂及其制备方法和应用
WO2018081814A1 (en) 2016-10-31 2018-05-03 University Of Kansas Grp94 selective inhibitors and uses thereof
WO2019040869A1 (en) * 2017-08-25 2019-02-28 The Trustees Of Columbia University In The City Of New York INHIBITORS OF IMPORTS OF PURINE IN PARASITES AND USES OF THESE INHIBITORS
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110590686B (zh) * 2019-10-31 2022-10-25 重庆大学 一种氮杂糖基1,2,3-三氮唑核苷化合物及其制备方法和应用
WO2021137665A1 (ko) * 2019-12-30 2021-07-08 이화여자대학교 산학협력단 Hsp90 억제제로서의 1,2,3-트리아졸 유도체 화합물 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10315570A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Triazolderivate
GB0315111D0 (en) * 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
GB0323810D0 (en) 2003-10-10 2003-11-12 Cancer Rec Tech Ltd Pyridothiophene compounds
EP1817295B1 (en) 2004-11-18 2012-11-07 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
EP1867331A4 (en) 2005-04-06 2009-04-08 Takeda Pharmaceutical TRIAZOLE DERIVATIVE AND USE THEREOF
JP2006306755A (ja) * 2005-04-27 2006-11-09 Nippon Kayaku Co Ltd 新規なピラゾール誘導体とそれを有効成分とするhsp90阻害剤
JP5149177B2 (ja) * 2005-07-25 2013-02-20 シンタ ファーマシューティカルズ コーポレーション 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤
JP5548364B2 (ja) * 2006-10-03 2014-07-16 日本化薬株式会社 レゾルシノール誘導体の高分子結合体
PL2118077T3 (pl) * 2007-02-08 2015-05-29 Synta Pharmaceuticals Corp Związki triazolowe modulujące aktywność hsp90
US20110065725A1 (en) 2008-03-18 2011-03-17 Glaxo Group Limited Triazole amide derivatives for use in therapy
LT5623B (lt) 2008-04-30 2010-01-25 Biotechnologijos Institutas, , 5-aril-4-(5-pakeistieji 2,4-dihidroksifenil)-1,2,3-tiadiazolai kaip hsp90 šaperono slopikliai ir tarpiniai junginiai jiems gauti
US9156836B2 (en) 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
WO2010017545A2 (en) 2008-08-08 2010-02-11 Synta Pharamceuticals Corp. Triazole compounds that modulate hsp90 activity
US9126953B2 (en) 2008-08-08 2015-09-08 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity

Similar Documents

Publication Publication Date Title
JP2014501232A5 (2)
ME02144B (me) Jedinjenja aril triazola sa antitumorskom aktivnošću
AU2017351688B2 (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
ES2536191T3 (es) Derivados de sulfonamida
CN101622245B (zh) 杀真菌酰胺
JP2009507080A5 (2)
JP2014511869A5 (2)
JP6605020B2 (ja) Nr2b受容体阻害剤としてのトリアゾール
JP2018503661A5 (2)
EA010132B1 (ru) Производные триазола в качестве антагонистов вазопрессина
RU2501791C2 (ru) Производное триазола или его соль
JP2015529192A5 (2)
EP3464248A1 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
JP2007039461A5 (2)
JP2013510859A5 (2)
JP2013519680A5 (2)
JP2017524026A5 (2)
JP2008517976A5 (2)
JP2017214387A5 (2)
JP2017524019A5 (2)
JP2016530322A5 (2)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
HRP20220327T1 (hr) Supstituirani triazoli i postupci koji se na njih odnose
JP2020516659A5 (2)